CMS: Share Buy-Back Program - 4th Interim Announcement

EQS Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA / Share Buy-Back Program - 4th Interim Announcement Share Buy-Back Program - 4th Interim Announcement 22.04.2024 / 17:17 CET/CEST Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. CompuGroup Medical SE: Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program – 4th Interim Announcement In the period from April 15, 2024 until and including April 19, 2024, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 106,540 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on March 26, 2024. The aggregate number of shares bought back each day during the period from April 15, 2024 until and including April 19, 2024 as well as the daily volume-weighted average prices for such buy-backs are as follows:   Date Aggregate volume (number of no-par value shares) Volume-weighted average price (in EUR, excluding ancillary costs and charges) April 15, 2024 21,350 29.9373 April 16, 2024 34,343 29.0553 April 17, 2024 10,000 29.2615 April 18, 2024 20,847 29.1385 April 19, 2024 20,000 29.0579 Total: 106,540 29.2682 The aggregate number of shares bought back within the share buy-back program in the period from March 26, 2024 until and including April 19, 2024 amounts to 380,536 shares. Detailed information about the transactions are published on the company‘s website under https://www.cgm.com/corp_en/company/ir-en/share.html . The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading). Koblenz, April 22, 2024 CompuGroup Medical SE & Co. KGaA The general partner   22.04.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	CompuGroup Medical SE & Co. KGaA
	Maria Trost 21
	56070 Koblenz
	Germany
Internet:	www.cgm.com

End of News	EQS News Service

1886319  22.04.2024 CET/CEST